{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:28:22Z","timestamp":1790364502595,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UK Economic Social and Research Council","award":["ES\/102803X\/1"],"award-info":[{"award-number":["ES\/102803X\/1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.exger.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T22:32:51Z","timestamp":1507847571000},"page":"146-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Homocysteine concentrations in the cognitive progression of Alzheimer's disease"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-2547","authenticated-orcid":false,"given":"Nicolas","family":"Farina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Jerner\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Tabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2017.10.008_bb0005","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose b vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.exger.2017.10.008_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell scale for depression in dementia","volume":"23","author":"Alexopoulos","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.exger.2017.10.008_bb0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1079\/PHN2000102","article-title":"Nutritional methods in the European prospective investigation of cancer in Norfolk","volume":"4","author":"Bingham","year":"2007","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.exger.2017.10.008_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12603-012-0051-y","article-title":"Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the vita cohort","volume":"16","author":"Blasko","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.exger.2017.10.008_bb0025","first-page":"208","article-title":"Drugs for Alzheimer's disease: are they effective?","volume":"35","author":"Casey","year":"2010","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.exger.2017.10.008_bb0030","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.exger.2017.10.008_bb0035","series-title":"Dietary Reference Values for Food, Energy and Nutrients for the United Kingdom: Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy","author":"Department of Health","year":"1991"},{"key":"10.1016\/j.exger.2017.10.008_bb0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13825585.2015.1080213","article-title":"The relationship between habitual physical activity status and executive function in individuals with Alzheimer's disease: a longitudinal, cross-lagged panel analysis","volume":"23","author":"Farina","year":"2016","journal-title":"Aging Neuropsychol. Cogn."},{"key":"10.1016\/j.exger.2017.10.008_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clinbiochem.2004.02.007","article-title":"Increasing production of homocysteine and neopterin and degradation of tryptophan with older age","volume":"37","author":"Frick","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.exger.2017.10.008_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jclinpath-2015-203502","article-title":"Laboratory assessment of vitamin B12 status","volume":"70","author":"Harrington","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.exger.2017.10.008_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/156720510792231702","article-title":"Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up","volume":"7","author":"Huang","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.exger.2017.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ene.12159","article-title":"Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia","volume":"20","author":"Huang","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.exger.2017.10.008_bb0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2017.10.008_bb0070","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.114.103283","article-title":"Brain atrophy in cognitively impaired elderly: the importance of long-chain \u03c9-3 fatty acids and B vitamin status in a randomized controlled trial","author":"Jerner\u00e9n","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exger.2017.10.008_bb0075","doi-asserted-by":"crossref","first-page":"M76","DOI":"10.1093\/gerona\/52A.2.M76","article-title":"Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?","volume":"52A","author":"Joosten","year":"1997","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2017.10.008_bb0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/jcp.44.7.592","article-title":"Microbiological assay for vitamin B12 performed in 96-well microtitre plates","volume":"44","author":"Kelleher","year":"1991","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.exger.2017.10.008_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clnu.2010.12.004","article-title":"A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people","volume":"30","author":"Kwok","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.exger.2017.10.008_bb0090","series-title":"Neurobiol. Aging, Novel Imaging Biomarkers for Alzheimer's Disease and Related Disorders (NIBAD)","first-page":"S203","article-title":"Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's disease neuroimaging initiative","volume":"36","author":"Madsen","year":"2015"},{"key":"10.1016\/j.exger.2017.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke's cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2017.10.008_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0076-6879(97)81007-5","article-title":"Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method","volume":"281","author":"Molloy","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.exger.2017.10.008_bb0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3945\/an.112.002535","article-title":"The role of B vitamins in preventing and treating cognitive impairment and decline","volume":"3","author":"Morris","year":"2012","journal-title":"Adv. Nutr. Int. Rev. J."},{"key":"10.1016\/j.exger.2017.10.008_bb0110","series-title":"National Adult Reading Test (NART): For the Assessment of Premorbid Intelligence in Patients with Dementia: Test Manual","author":"Nelson","year":"1982"},{"key":"10.1016\/j.exger.2017.10.008_bb0115","doi-asserted-by":"crossref","first-page":"359S","DOI":"10.3945\/ajcn.111.013458","article-title":"Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility12345","volume":"94","author":"Nexo","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exger.2017.10.008_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gps.2303","article-title":"Homocysteine as a predictor of cognitive decline in Alzheimer's disease","volume":"25","author":"Oulhaj","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2017.10.008_bb0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-150777","article-title":"Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment","volume":"50","author":"Oulhaj","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2017.10.008_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about Total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.exger.2017.10.008_bb0135","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.exger.2017.10.008_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/01688639708403855","article-title":"Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables","volume":"19","author":"Small","year":"1997","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.exger.2017.10.008_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1037\/0894-4105.11.3.413","article-title":"Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study","volume":"11","author":"Small","year":"1997","journal-title":"Neuropsychology"},{"key":"10.1016\/j.exger.2017.10.008_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2011.02485.x","article-title":"Do we need to reconsider the desirable blood level of vitamin B12?","volume":"271","author":"Smith","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.exger.2017.10.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2017.10.008_bb0160","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.clinthera.2007.10.012","article-title":"Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients","volume":"29","author":"Sun","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.exger.2017.10.008_bb0165","first-page":"168","article-title":"Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6months follow-up period","volume":"19","author":"Tu","year":"2010","journal-title":"Acta Neurol. Taiwanica"},{"key":"10.1016\/j.exger.2017.10.008_bb0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1742-1241.2009.02026.x","article-title":"Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature","volume":"63","author":"Vogel","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.exger.2017.10.008_bb0175","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.exger.2017.10.008_bb0180","series-title":"Serum and Red Blood Cell Folate Concentrations for Assessing Folate Status in Populations","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.exger.2017.10.008_bb0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","article-title":"Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?","volume":"32","author":"Zhuo","year":"2011","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556517303741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556517303741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:49:37Z","timestamp":1719514177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556517303741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"alternative-id":["S0531556517303741"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2017.10.008","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine concentrations in the cognitive progression of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}